IMNM Projected Dividend Yield
Immunome Inc ( NASDAQ : IMNM )Immunome is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop antibody therapeutics designed to change the way diseases are being treated. Co.'s primary focus areas are oncology and infectious disease. Co. is advancing two programs: a three-antibody cocktail (IMM-BCP-01) for potential treatment and prophylaxis of SARS-CoV-2, and an antibody (IMM-ONC-01) against interleukin 38, an immune checkpoint, for the potential treatment of various solid tumors. 20 YEAR PERFORMANCE RESULTS |
IMNM Dividend History Detail IMNM Dividend News IMNM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |